Codexis Inc. (NASDAQ: CDXS) is 21.97% higher on its value in year-to-date trading and has touched a low of $1.45 and a high of $5.07 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDXS stock was last observed hovering at around $4.15 in the last trading session, with the day’s loss setting it -0.43%.
Currently trading at $3.72, the stock is 25.86% and 26.88% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.29 million and changing -10.36% at the moment leaves the stock 52.27% off its SMA200. CDXS registered -19.65% loss for a year compared to 6-month gain of 120.12%. The firm has a 50-day simple moving average (SMA 50) of $2.77 and a 200-day simple moving average (SMA200) of -$3.76.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 30.53% loss in the last 1 month and extending the period to 3 months gives it a 72.22%, and is 30.53% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.81% over the week and 9.30% over the month.
Codexis Inc. (CDXS) has around 248 employees, a market worth around $259.77M and $73.96M in sales. Profit margin for the company is -110.41%. Distance from 52-week low is 156.55% and -26.55% from its 52-week high. The company has generated returns on investments over the last 12 months (-77.97%).
Codexis Inc. quarterly earnings per share for the current quarter are estimated at -$0.12 with sales reaching $19.9M over the same period.The EPS is expected to grow by 41.25% this year, but quarterly earnings will post -52.80% year-over-year. Quarterly sales are estimated to shrink -34.50% in year-over-year returns.
168 institutions hold shares in Codexis Inc. (CDXS), with institutional investors hold 85.60% of the company’s shares. The shares outstanding are 69.83M, and float is at 66.80M with Short Float at 3.77%. Institutions hold 83.31% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 6.6 million shares valued at $18.49 million. The investor’s holdings represent 9.46% of the CDXS Shares outstanding. As of Jun 29, 2023, the second largest holder is Baillie Gifford and Company with 6.14 million shares valued at $17.19 million to account for 8.80% of the shares outstanding. The other top investors are Nantahala Capital Management, LLC which holds 5.04 million shares representing 7.21% and valued at over $14.1 million, while Vanguard Group Inc holds 5.29% of the shares totaling 3.69 million with a market value of $10.34 million.
Codexis Inc. (CDXS) Insider Activity
A total of 5 insider transactions have happened at Codexis Inc. (CDXS) in the last six months, with sales accounting for 1 and purchases happening 4 times. The most recent transaction is an insider sale by Dorgan Byron L, the company’s Director. SEC filings show that Dorgan Byron L sold 20,000 shares of the company’s common stock on Nov 15 at a price of $2.11 per share for a total of $42168.0. Following the sale, the insider now owns 0.19 million shares.
Codexis Inc. disclosed in a document filed with the SEC on Sep 11 that Norrett Kevin (Chief Operating Officer) bought a total of 9,000 shares of the company’s common stock. The trade occurred on Sep 11 and was made at $1.72 per share for $15479.0. Following the transaction, the insider now directly holds 98102.0 shares of the CDXS stock.
Still, SEC filings show that on Sep 08, DILLY STEPHEN GEORGE () acquired 58,479 shares at an average price of $1.73 for $0.1 million. The insider now directly holds 438,878 shares of Codexis Inc. (CDXS).
Codexis Inc. (CDXS): Who are the competitors?
One of the company’s main competitors (and peers) include Balchem Corp. (BCPC) that is trading 16.14% up over the past 12 months.Pfizer Inc. (PFE) lies in the list of competitors of the Codexis Inc. and is -32.70% lower over the same period from CDXSShell PLC ADR (SHEL) is 1.03% up on the 1-year trading charts.
